Effects of Sweeteners on the Gut Microbiota: A Review of Experimental Studies and Clinical Trials

Advances in Nutrition

Volumn 10, Issue , 2019, Pages S31-S48

  Ruiz Ojeda, Francisco Javier ^a,b   Plaza Díaz, Julio ^a,b   Sáez Lara, Maria Jose ^a   Gil, Angel ^a,b,c  

^a UNIVERSITY OF GRANADA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^c Instituto de Salud Carlos III   (Spain)

Author keywords

microbiota; nonnutritive sweeteners; nutritive sweeteners; sweetening agents; tabletop sweeteners

Indexed keywords

EID: 85061120516     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.1093/advances/nmy037     Document Type: Conference Paper

References (101)

1. Stanhope KL. Sugar consumption, metabolic disease and obesity: the state of the controversy. Crit Rev Clin Lab Sci 2016;53:52-67.
2. Lohner S, Toews I, Meerpohl JJ. Health outcomes of non-nutritive sweeteners: analysis of the research landscape. Nutr J 2017; 16:55.
3. Shallenberger RS, Acree TE. Chemical structure of compounds and their sweet and bitter taste. In: Handbook of sensory physiology. Berlin: Springer-Verlag; 1971;51:221-77.
4. Chattopadhyay S, Raychaudhuri U, Chakraborty R. Artificial sweeteners - a review. J Food Sci Technol 2014;51(4):611-21.
5. CarochoM,Morales P, Ferreira ICFR. Sweeteners as food additives in the XXI century: a reviewof what is known, andwhat is to come. Food Chem Toxicol 2017;107(Part A):302-17.
6. FDA. High-intensity sweeteners. 2015. Available from: www.fda. gov/food/ingredientspackaginglabeling/foodadditivesingredients/ ucm397716.htm, Accessed 2014.
7. Food Standards Agency. Current EU approved additives and their E numbers. 2016. [cited 2018 Jan 13]. Available from: https://www.food.gov.uk/science/additives/enumberlist#toc-4.
8. Fowler SP, Williams K, Resendez RG, Hunt KJ, Hazuda HP, Stern MP. Fueling the obesity epidemic? Artificially sweetened beverage use and long-term weight gain. Obesity (Silver Spring) 2008;16: 1894-900.
9. Lutsey PL, Steffen LM, Stevens J. Dietary intake and the development of the metabolic syndrome: the Atherosclerosis Risk in Communities Study. Circulation 2008;117:754-61.
10. Nettleton JA, Lutsey PL, Wang Y, Lima JA, Michos ED, Jacobs DR Jr. Diet soda intake and risk of incident metabolic syndrome and type 2 diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 2009;32:688-94.
11. Fagherazzi G, Vilier A, Saes Sartorelli D, Lajous M, Balkau B, Clavel-Chapelon F. Consumption of artificially and sugar-sweetened beverages and incident type 2 diabetes in the Etude Epidemiologique aupres des femmes de laMutuelleGenerale de l'EducationNationale - European Prospective Investigation into Cancer and Nutrition cohort. Am J Clin Nutr 2013;97:517-23.
12. Pepino MY. Metabolic effects of non-nutritive sweeteners. Physiol Behav 2015;152:450-5.
13. Schulze MB, Manson JE, Ludwig DS, Colditz GA, Stampfer MJ, Willett WC, Hu FB. Sugarsweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA 2004;292:927-34.
14. Swithers SE. Artificial sweeteners produce the counterintuitive effect of inducing metabolic derangements. Trends Endocrinol Metab 2013;24:431-41.
15. Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA,Maza O, Israeli D, Zmora N, Gilad S,Weinberger A,, et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 2014;514:181-6.
16. Tucker RM, Tan SY. Do non-nutritive sweeteners influence acute glucose homeostasis in humans? A systematic review. Physiol Behav 2017;182:17-26.
17. LiveseyG.Health potential of polyols as sugar replacers, with emphasis on low glycaemic properties. Nutr Res Rev 2003;16:163e191.
18. Bokulich NA, Blaser MJ. A bitter aftertaste: unintended effects of artificial sweeteners on the gut microbiome. Cell Metab 2014;20: 701-3.
19. Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell 2012;148: 1258-70.
20. Suez J, KoremT, Zilberman-SchapiraG, Segal E, Elinav E.Non-caloric artificial sweeteners and themicrobiome: findings and challenges. Gut Microbes 2015;6:149-55.
21. Renwick AG. The metabolism of intense sweeteners. Xenobiotica 1986;16:1057-71.
22. Pfeffer M, Ziesenitz SC, Siebert G. Acesulfame K, cyclamate and saccharin inhibit the anaerobic fermentation of glucose by intestinal bacteria. Z Ernahrungswiss 1985;24:231-5.
23. Frankenfeld CL, Sikaroodi M, Lamb E, Shoemaker S, Gillevet PM. High-intensity sweetener consumption and gut microbiome content and predicted gene function in a cross-sectional study of adults in the United States. Ann Epidemiol 2015;25:736-42, e4.
24. Uebanso T, Ohnishi A, Kitayama R, Yoshimoto A, Nakahashi M, Shimohata T, Mawatari K, Takahashi A. Effects of low-dose noncaloric sweetener consumption on gut microbiota in mice. Nutrients 2017;9:E560.
25. Bian X, Chi L, Gao B, Tu P, Ru H, Lu K. The artificial sweetener acesulfamepotassiumaffects the gutmicrobiome and bodyweight gain in CD-1 mice. PLoS One 2017;12:e0178426.
26. HorwitzDL,McLane M, Kobe P. Response to single dose of aspartame or saccharin by NIDDM patients. Diabetes Care 1988;11:230-4.
27. Tordoff MG, Alleva AM. Effect of drinking soda sweetened with aspartame or high-fructose corn syrup on food intake and body weight. Am J Clin Nutr 1990;51:963-9.
28. Palmnäs MS, Cowan TE, Bomhof MR, Su J, Reimer RA, Vogel HJ, Hittel DS, Shearer J. Low-dose aspartame consumption differentially affects gut microbiota-host metabolic interactions in the diet-induced obese rat. PLoS One 2014;9:e109841.
29. Magnuson BA, Burdock GA, Doull J, Kroes RM, Marsh GM, Pariza MW, Spencer PS, Waddell WJ, Walker R, Williams GM. Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies". Crit Rev Toxicol 2007;37:629-727.
30. Magnuson BA, Carakostas MC, Moore NH, Poulos SP, Renwick AG. Biological fate of low-calorie sweeteners. Nutr Rev 2016;74(11):670-89.
31. Mitchell H. Sweeteners and sugar alternatives in food technology. Oxford (United Kingdom): Blackwell Publishing; 2006.
32. Nofre C, Tinti J. Neotame: discovery, properties, utility. Food Chem 2000;69:245, e257.
33. Zhu L, Wang G, Dong B, Peng CC, Tian YY, Gong LM. Effects on sweetener neotameon diet preference, performance and hematological and biochemical parameters of weaned piglets. Anim Feed Sci Technol 2016;214:86e94.
34. Otabe A, Fujieda T, Masuyama T. In vitro and in vivo assessment of the mutagenic activity of N-[N-[3-(3-hydroxy-4-methoxyphenyl) propyl]-α-aspartyl]-L-phenylalanine 1-methyl ester, monohydrate (advantame). Food Chem Toxicol 2011;49(Suppl 1):S30-4.
35. Price JM, Biava CG, Oser BL, Vogin EE, Steinfeld J, Ley HL. Bladder tumors in rats fed cyclohexylamine or high doses of a mixture of cyclamate and saccharin. Science 1970;167:1131-2.
36. Oser BL, Carson S, Cox GE, Vogin EE, Sternberg SS. Chronic toxicity study of cyclamate: saccharin (10:1) in rats. Toxicology 1975;4:315-30.
37. Ahmed FE, Thomas DB. Assessment of the carcinogenicity of the nonnutritive sweetener cyclamate. Crit Rev Toxicol 1992;22:81- 118.
38. Drasar BS, Renwick AG, Williams RT. The role of the gut flora in the metabolism of cyclamate. Biochem J 1972;129:881-90.
39. Mallett AK, Rowland IR, Bearne CA, Purchase R, Gangolli SD. Metabolic adaptation of rat faecal microflora to cyclamate in vitro. Food Chem Toxicol 1985;23:1029-34.
40. Goldin BR. Intestinal microflora: metabolism of drugs and carcinogens. Ann Med 1990;22:43-8.
41. Anderson RL, Kirkland JJ. The effect of sodium saccharin in the diet on caecal microflora. Food Cosmet Toxicol 1980;18:353-5.
42. Naim M, Zechman JM, Brand JG, Kare MR, Sandovsky V. Effects of sodium saccharin on the activity of trypsin, chymotrypsin, and amylase and upon bacteria in small intestinal contents of rats. Proc Soc Exp Biol Med 1985;178:392-401.
43. Daly K, Darby AC, Hall N, Nau A, Bravo D, Shirazi-Beechey SP. Dietary supplementation with lactose or artificial sweetener enhances swine gut Lactobacillus population abundance. Br J Nutr 2014;111:S30-5.
44. Daly K, Darby AC, Hall N, Wilkinson MC, Pongchaikul P, Bravo D, Shirazi-Beechey SP. Bacterial sensing underlies artificial sweetener-induced growth of gut Lactobacillus. Environ Microbiol 2016;18:2159-71.
45. Labrecque MT, Malone D, Caldwell KE, Allan AM. Impact of ethanol and saccharin on fecal microbiome in pregnant and non-pregnant mice. J Pregnancy Child Health 2015;2:1000193.
46. Bian X, Tu P, Chi L, Gao B, Ru H, Lu K. Saccharin induced liver inflammation in mice by altering the gut microbiota and its metabolic functions. Food Chem Toxicol 2017;107:530-9.
47. Roberts A, Renwick AG, Sims J, Snodin DJ. Sucralose metabolism and pharmakinetics in man. Food Chem Toxicol 2008;38:S31eS41.
48. Abou-Donia MB, El-Masry EM, Abdel-Rahman AA, McLendon RE, Schiffman SS. Splenda alters gut microflora and increases intestinal p-glycoprotein and cytochrome p-450 in male rats. J Toxicol Environ Health A 2008;71:1415-29.
49. Uebanso T, Kano S, YoshimotoA,Naito C, Shimohata T,MawatariK, Takahashi A. Effects of consuming xylitol on gut microbiota and lipid metabolism in mice. Nutrients 2017;9:E756.
50. Bian X, Chi L, Gao B, Tu P, Ru H, Lu K. Gut microbiome response to sucralose and its potential role in inducing liver inflammation in mice. Front Physiol 2017;8:487.
51. Soejima A, Tanabe AS, Takayama I, Kawahara T, Watanabe K, Nakazawa M, Mishima M, Yahara T. Phylogeny and biogeography of the genus Stevia (Astareaceae: Eupatorieae): an example of diversification in the Asteraceae in the new world. J Plant Res 2017;130:953-72.
52. Ferrazzano GF, Cantile T, Alcidi B, Coda M, Ingenito A, Zarrelli A, Di Fabio G, Pollio A. Is Stevia rebaudiana Bertoni a non cariogenic sweetener? A review. Molecules 2015;21:E38.
53. European Food Safety Authority. Scientific opinion on the safety of steviol glycosides for the proposed uses as a food additive. EFSA Panel of Food Additive and Nutrients Sources added to Food (ANS). EFSA J 2010;8(4):1537.
54. European Food Safety Authority. Scientific opinion on the safety of the proposed amendment of the specifications for steviol glycosides (E960) as a food additive. EFSA Panel of Food Additive and Nutrient Sources added to Food (ANS). EFSA J 2015;13(12):4316.
55. Koyama E, Kitazawa K, Ohori Y, Izawa O, Kakegawa K, Fujino A, Ui M. In vitrometabolism of the glycosidic sweeteners, steviamixture and enzymatically modified stevia in human intestinal microflora. Food Chem Toxicol 2003;41:359-74.
56. Gardana C, Simonetti P, Canzi E, Zanchi R, Pietta P. Metabolims of stevioside and rebaudioside A from Stevia rebaudiana extracts by human microflora. J Agric Food Chem 2003;51:6618-22.
57. Renwick AG, Tarka SM. Microbial hydrolysis of steviol glycosides. Food Chem Toxicol 2008;46:S70-4.
58. Sanches Lopes SM, Francisco MG, Higashi B, de Almeida RTR, Krausová G, Pilau EJ, Gonçalves JE, Gonçalves RAC, Oliveira AJB. Chemical characterization and prebiotic activity of fructooligosaccharides from Stevia rebaudiana (Bertoni) roots and in vitro adventitious root cultures. Carbohydr Polym 2016;152:718-25.
59. Roohbakhsh A, Iranshahy M, Iranshahi M. Glycyrrhetinic acid and its derivatives: anti-cancer and cancer chemopreventive properties, mechanisms of action and structure-cytotoxic activity relationship. Curr Med Chem 2016;23:498-517.
60. Kim YS, Kim JJ, Cho KH, Jung WS, Moon SK, Park EK, Kim DH. Biotransformation of ginsenoside Rb1, crocin, amygdalin, geniposide, puerarin, ginsenoside Re, hesperidin, poncirin, glycyrrhizin, and baicalin by human fecal microflora and its relation to cytotoxicity against tumor cells. J Microbiol Biotechnol 2008;18:1109-14.
61. Yu K, Chen F, Li C. Absorption, disposition, and pharmacokinetics of saponins from Chinese medicinal herbs: what do we know and what do we need to know more? Curr Drug Metab 2012;13:577-98.
62. Kim DH, Hong SW, Kim BT, Bae EA, Park HY, Han MJ. Biotransformation of glycyrrhizin by human intestinal bacteria and its relation to biological activities. Arch Pharm Res 2000;23: 172-7.
63. Yim JS, Kim YS, Moon SK, Bae HS, Kim JJ, Park EK, Dim DH. Metabolic activities of ginsenoside Rb1, baicalin, glycyrrhizin and geniposide to their bioactive compounds by human intestinal microflora. Biol Pharm Bull 2004;10:1580-3.
64. Leone S, PiconeD.Molecular dynamics driven design of pH-stabilized mutants of MNEI, a sweet protein. PloS One 2016;11:e0158372.
65. Grembecka M. Sugar alcohols - their role in the modern world of sweeteners: a review. Eur Food Res Technol 2015;241:1-14.
66. Lenhart A, Chey WD. A systematic review of the effects of polyols on gastrointestinal health and irritable bowel syndrome. Adv Nutr 2017;8(4):587-96.
67. European Food Safety Authority. Call for technical and toxicological data on sweeteners authorised as food additives in the EU. 2017. Available from: https://www.efsa.europa.eu/en/data/call/170621.
68. Bernt WO, Borzelleca JF, Flamm G, Munro IC. Erythritol: a review of biological and toxicological studies. Regul Toxicol Pharmacol 1996;24:S191-7.
69. Goossens J, Röper H. Erythritol: a new sweetener. Vilvoorde (Belgium): Cerestar R&D, Euro Centre Food; 1994.
70. Kawanabe J, Hirasawa M, Takeuchi T, Oda T, Ikeda T. Noncariogenicity of erythritol as a substrate. Caries Res 1992;26:358-62.
71. Arrigoni E, Brouns F, Amadò R. Human gut microbiota does not ferment erythritol. Br J Nutr 2005;94:643-6.
72. Bornet FR, Blayo A, Dauchy F, Slama G. Gastrointestinal response and plasma and urine determinations in human subjects given erythritol. Regul Toxicol Pharmacol 1996;24:S296-302.
73. Ishikawa M, Miyashita M, Kawashima Y, Nakamura T, Saitou N, Modderman J. Effects of oral administration of erythritol on patients with diabetes. Regul Toxicol Pharmacol 1996;24: S303-8.
74. Van Ommen B, de Bie B, Bär A. Disposition of 14C-erythritol in germfree and conventional rats. Regul Toxicol Pharmacol 1996;24:S198-205.
75. Gostner A, Schäffer V, Theis S, Menzel T, Lührs H, Melcher R, Schauber J, Kudlich T, Dusel G, Dorbath D, et al. Effects of isomalt consumption on gastrointestinal and metabolic parameters in healthy volunteers. Br J Nutr 2005;94(4):575-81.
76. GostnerA, BlautM, SchäfferV, KozianowskiG, Theis S, KlingebergM, Dombrowski Y, Martin D, Ehrhardt S, Taras D, et al. Effect of isomalt consumption on faecal microflora and colonic metabolism in healthy volunteers. Br J Nutr 2006;95(1):40-50.
77. Schauber J, Weiler F, Gostner A, Melcher R, Kudlich T, Lührs H, Scheppach W. Human rectal mucosal gene expression after consumption of digestible and non-digestible carbohydrates.MolNutr Food Res 2006;50:1006-12.
78. Patil DH, Grimble GK, Silk DB. Lactitol, a new hydrogenated lactose derivative: intestinal absorption and laxative threshold in normal human subjects. Br J Nutr 1987;57(2):195-9.
79. Piva A, Panciroli A, Meola E, Formigoni A. Lactitol enhances shortchain fatty acid and gas production by swine cecal microflora to a greater extent when fermenting low rather than high fiber diets. Nutrient Metab 1996;126(1):280-9.
80. Ackerman DL, Craft KM, Townsend SD. Infant food applications of complex carbohydrates: structure, synthesis, and function. Carbohydr Res 2017;437:16-27.
81. Pinna C, Stefanelli C, Biagi G. In vitro effect of dietary protein level and nondigestible oligosaccharides on feline fecal microbiota. J Anim Sci 2014;92:5593-602
82. Ballongue J, Schumann C, Quignon P. Effects of lactulose and lactitol on colonic microflora and enzymatic activity. Scand J Gastroenterol Suppl 1997;222:41-4.
83. Peuranen S, Tiihonen K, Apajalahti J, Kettunen A, Saarinen M, Rautonen N. Combination of polydextrose and lactitol affects microbial ecosystem and immune responses in rat gastrointestinal tract. Br J Nutr 2004;91:905-14.
84. Ouwehand AC, Tiihonen K, Saarinen M, Putaala H, Rautonen N. Influence of a combination of Lactobacillus acidophilus NCFM and lactitol on healthy elderly: intestinal and immune parameters. Br JNutr 2009;101:367-75.
85. Björklund M, Ouwehand AC, Forssten SD, Nikkilä J, Tiihonen K, Rautonen N, Lahtinen SJ. Gut microbiota of healthy elderly NSAID users is selectively modified with the administration of Lactobacillus acidophilus NCFM and lactitol. Age (Dordr) 2012;34(4):987-99.
86. Finney M, Smullen J, Foster HA, Brokx S, Storey DM. Effects of low doses of lactitol on faecal microflora, pH, short chain fatty acids and gastrointestinal symptomology. Eur J Nutr 2007;46:307-14.
87. Joshi K, Kumari A, Arora S, Singh AK. Development of an analytical protocol for the estimation of maltitol from yoghurt, burfi and flavoured milk. Food Sci Technol 2016;70:41, e45.
88. Beards E, Tuohy K, Gibson G. A human volunteer study to assess the impact of confectionery sweeteners on the gut microbiota composition. Br J Nutr 2010;104:701-8.
89. Hyams JS. Sorbitol intolerance: an unappreciatedcause of functional gastrointestinal complaints. Gastroenterology 1983;84:30-3.
90. Yao CK, Tan HL, van Langenberg DR, Barrett JS, Rose R, Liels K, Gibson PR, Muir JG. Dietary sorbitol and mannitol: food content and distinct absorption patterns between healthy individuals and patients with irritable bowel syndrome. J Hum Nutr Diet 2014;27:263, e275.
91. Corazza GR, Strocchi A, Rossi R, Sirola D, Gasbarrini G. Sorbitol malabsorption in normal volunteers and in patients with coeliac disease. Gut 1988;29:44-8.
92. Zumbé A, Lee A, Storey D. Polyols in confectionery: the route to sugarfree, reduced sugar and reduced calorie confectionery. Br J Nutr 2001;85(Suppl 1):S31-45.
93. Symons P, Jones MP, Kellow JE. Symptom provocation in irritable bowel syndrome: effects of differing doses of fructose-sorbitol. Scand J Gastroenterol 1992;27:940-4.
94. Biesiekierski JR, Rosella O, Rose R, Liels K, Barrett JS, Shepherd SJ, Gibson PR, Muir JG. Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cereals. J Hum Nutr Diet 2011;24:154, e176.
95. Lee J. Sorbitol, Rubus fruit, and misconception. Food Chem 2015;166:616, e622.
96. Tamura M, Hoshi C, Hori S. Xylitol affects the intestinal microbiota and metabolism of daidzein in adult male mice. Int J Mol Sci 2013;14:23993-4007.
97. Salminen S, Salminen E, Koivistoinen P, Bridges J, Marks V. Gut microflora interactions with xylitol in the mouse, rat and man. Food Chem Toxicol 1985;23:985-90.
98. Sato T, Kusuhara S, Yokoi W, Ito M,Miyazaki K. Prebiotic potential of L-sorbose and xylitol in promoting the growth and metabolic activity of specific butyrate-producing bacteria in human fecal culture. FEMS Microbiol Ecol 2017;93(1):227.
99. Naaber P, Mikelsaar RH, Salminen S, Mikelsaar M. Bacterial translocation, intestinal microflora and morphological changes of intestinal mucosa in experimental models of Clostridium difficile infection. J Med Microbiol 1998;47(7):591-8.
100. Greenhill C. Gut microbiota: not so sweet - artificial sweeteners can cause glucose intolerance by affecting the gut microbiota. Nat Rev Endocrinol 2014;10:637.
101. Swithers SE, Shearer J. Obesity: sweetener associated with increased adiposity in young adults. Nat Rev Endocrinol 2017;13:443-4.